Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female outpatients, aged 2 to 6 years presenting tympanic temperature ≥ 38.5 ° C and no greater than 39.5° C, associated with acute upper respiratory tract infections~* Parents or legal representatives who have provided written informed consent and provided a phone number for the call at end of study~Exclusion Criteria:~* History of hypersensitivity to any drugs or excipients of the study~* Any medication, surgical, or medical condition, which might significantly alter the absorption, distribution, metabolism, or excretion of medications~* Background or suspected hematological disorders, febrile seizures, asthma, peptic ulcer or gastrointestinal bleeding~* Neurological and hemodynamics disorders~* Evidence of liver or kidney impairment or heart failure~* Patients who have received previous treatment with antipyretics; acetaminophen (up to 4 hrs), NSAIDs (up to 6 hrs) or antibiotic therapy (at least 12 hours)~* Any surgical or medical condition, which in the opinion of the investigator, may place the patient at risk~Other protocol-defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- Diclofenac potassium (Type: EXPERIMENTAL): None
- Acetaminophen (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).